Beneficial effect of interleukin-1 receptor antagonist protein on spinal cord injury recovery in the rat

Inflammation

Volumn 35, Issue 2, 2012, Pages 520-526

  Zong, Shaohui ^a   Zeng, Gaofeng ^a   Wei, Bo ^a   Xiong, Chunxiang ^a   Zhao, Yuxi ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Behavior; Inflammation; Interleukin 1 receptor antagonist protein; Rat; Spinal cord injury

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GELATIN SPONGE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NEUROFILAMENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOTOR COORDINATION; MOTOR PERFORMANCE; NERVE REGENERATION; NISSL STAINING; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; UPREGULATION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; HINDLIMB; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MOTOR ACTIVITY; NEUROFILAMENT PROTEINS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; SPINAL CORD INJURIES;

RATTUS;

EID: 84863775298     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9341-5     Document Type: Article

References (21)

1. Sud, S., S.Y. Yang, C.H. Evans, P.D. Robbins, and P.H. Wooley. 2001. Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch. Inflammation 25: 361-372. (Pubitemid 33139696)
2. Bravo, G., R. Rojas-Martínez, F. Larios, E. Hong, G. Castañeda-Hernández, G. Rojas, and G. Guízar-Sahagún. 2001. Mechanisms involved in the cardiovascular alterations immediately after spinal cord injury. Life Sciences 68: 1527-1534. (Pubitemid 32168080)
3. Huang, H., S. Fan, X. Ji, Y. Zhang, F. Bao, and G. Zhang. 2009. Recombinant human erythropoietin protects against experimental spinal cord trauma injury by regulating expression of the proteins MKP-1 and p-ERK. The Journal of International Medical Research 37: 511-519.
4. Tzeng, S.F., H. Cheng, Y.S. Lee, J.P. Wu, B.J. Hoffer, and J.S. Kuo. 2001. Expression of neural cell adhesion molecule in spinal cords following a complete transection. Life Sciences 68(9): 1005-1012. (Pubitemid 32168052)
5. Johnson, R.W., S. Arkins, R. Dantzer, and K.W. Kelley. 1997. Hormones, lymphohemopoietic cytokines and the neuroimmune axis. Comparative Biochemistry and Physiology. Part A, Physiology 116: 183-201. (Pubitemid 27148078)
6. Xu, Z., B.R. Wang, X. Wang, F. Kuang, X.L. Duan, X.Y. Jiao, and G. Ju. 2006. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury. Life Sciences 79: 1895-1905. (Pubitemid 44485117)
7. Rothwell, N.J., and G.N. Luheshi. 2000. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends in Neurosciences 23: 618-625. (Pubitemid 32007888)
8. Wang, X.F., L.D. Huang, P.P. Yu, J.G. Hu, L. Yin, L. Wang, X.M. Xu, and P.H. Lu. 2006. Upregulation of type I interleukin-1 receptor after traumatic spinal cord injury in adult rats. Acta Neuropatho 111: 220-228.
9. Baamonde, A., V. Curto-Reyes, L. Juárez, A. Meana, A. Hidalgo, and L. Menéndez. 2007. Antihyperalgesic effects induced by the IL-1 receptor antagonist anakinra and increased IL-1beta levels in inflamed and osteosarcoma-bearing mice. Life Sciences 81: 673-682. (Pubitemid 47268018)
10. Rohleder, N., J.M. Wolf, I. Herpfer, B.L. Fiebich, C. Kirschbaum, and K. Lieb. 2006. No response of plasma substance P, but delayed increase of interleukin-1 receptor antagonist to acute psychosocial stress. Life Sciences 78: 3082-3089.
11. Wu, J., H. Yang, Z. Qiu, Q. Zhang, T. Ding, and D. Geng. 2010. Effect of combined treatment with methylprednisolone and Nogo-A monoclonal antibody after rat spinal cord injury. The Journal of International Medical Research 38: 570-582.
12. Khan, T., R.M. Havey, S.T. Sayers, A. Patwardhan, and W.W. King. 1999. Animal models of spinal cord contusion injuries. Laboratory Animal Science 49: 161-172. (Pubitemid 29207283)
13. Maharajh, G.S., E.A. Pascoe, W.C. Halliday, H.P. Grocott, D.B. Thiessen, L.G. Girling, M.S. Cheang, and W.A. Mutch. 1996. Neurological outcome in a porcine model of descending thoracic aortic surgery. Left atrial-femoral artery bypass versus clamp/repair. Stroke 27: 2095-2100.
14. Panico, A.M., P. Vicini, G. Massimo, V. Cardile, B. Gentile, S. Avondo, F. Vittorio, and G. Ronsisvalle. 2004. Protective effects of benzisothiazolylamidines on IL-1 beta induced alterations in human articular chondrocyte metabolism. Inflammation 28: 231-235. (Pubitemid 41449423)
15. Sanchez, C.P., and Y.Z. He. 2002. Alterations in the growth plate cartilage of rats with renal failure receiving corticosteroid therapy. Bone 30: 692-698. (Pubitemid 34467989)
16. Yao, H.W., J. Li, J.Q. Chen, and S.Y. Xu. 2004. A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells. Inflammation 28: 97-103. (Pubitemid 38932386)
17. Theodorou, V., J. Fioramonti, and L. Bueno. 1993. Recombinant interleukin-1 receptor antagonist protein prevents sensitization and intestinal anaphylaxis in guinea pigs. Life Sciences 53: 733-738.
18. Fitch, M.T., C. Doller, C.K. Combs, G.E. Landreth, and J. Silver. 1999. Cellular and molecular mechanisms of glial scarring and progressive cavitation: In vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. Journal of Neuroscience 19: 8182-8198. (Pubitemid 30226738)
19. Rapalino, O., O. Lazarov-Spiegler, E. Agranov, G.J. Velan, E. Yoles, M. Fraidakis, A. Solomon, R. Gepstein, A. Katz, M. Belkin, M. Hadani, and M. Schwartz. 1998. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 4: 814-821. (Pubitemid 28331023)
20. Kamei, N., N. Tanaka, Y. Oishi, T. Hamasaki, K. Nakanishi, N. Sakai, and M. Ochi. 2007. BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures. Spine 32: 1272-1278. (Pubitemid 46791444)
21. Sasaki, M., C. Radtke, A.M. Tan, P. Zhao, H. Hamada, K. Houkin, O. Honmou, and J.D. Kocsis. 2009. BDNF-hyper-secreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. The Journal of Neuroscience 29: 14932-14941.